Altaris Capital Partners to acquire Perrigo Rx business for $1.5bn

Altaris Capital Partners has agreed to acquire the prescription pharma (Rx) business of Perrigo Company plc, an Ireland-based pharma company, for about $1.55 billion. The ... Read More